|
|
|
Volumn 62, Issue 11, 2004, Pages 2116-2121
|
|
Anti-cytokine therapy for severe acute pancreatitis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
AUTACOID;
IMMUNOGLOBULIN G;
INFLIXIMAB;
INTERLEUKIN 1;
MACROPHAGE MIGRATION INHIBITION FACTOR;
MONOCLONAL ANTIBODY;
PYRROLIDINE DERIVATIVE;
PYRROLIDINE DITHIOCARBAMIC ACID;
THIOCARBAMIC ACID DERIVATIVE;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ACUTE DISEASE;
ANIMAL;
DISEASE MODEL;
DRUG ANTAGONISM;
DRUG DESIGN;
HOSPITALIZATION;
HUMAN;
PANCREATITIS;
REVIEW;
ACUTE DISEASE;
ANIMALS;
ANTIBODIES, MONOCLONAL;
DISEASE MODELS, ANIMAL;
DRUG DESIGN;
HUMANS;
IMMUNOGLOBULIN G;
INFLAMMATION MEDIATORS;
INTERLEUKIN-1;
MACROPHAGE MIGRATION-INHIBITORY FACTORS;
PANCREATITIS;
PYRROLIDINES;
RECEPTORS, TUMOR NECROSIS FACTOR;
SEVERITY OF ILLNESS INDEX;
THIOCARBAMATES;
TUMOR NECROSIS FACTOR-ALPHA;
|
|
EID: 16644389365
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (17)
|
|
References (20)
|
